Skip to main content
Premium Trial:

Request an Annual Quote

Enpicom ImmunoGenomiX Software V2.0

Dutch bioinformatics firm Enpicom has released version 2.0 of its ImmunoGenomiX (IGX) Platform for the management, analysis, and visualization of T- and B-cell receptor sequencing data. The new version supports single-cell sequencing data in addition to bulk sequencing data. The ability to analyze data from both single-cell and bulk sequencing workflows in tandem provides new opportunities for immunomics research and drug development, the company said. Other new enhancements include the IGX-Compare app, which allows users to compare any two data sets to visualize and prioritize matching clones; and more extensive data support, supporting the upload of readily annotated clone tables from, for instance, 10x Genomics or Adaptive Biotechnologies. The new version also features more clonotype grouping definitions and V/J gene usage plotting.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.